After generating $45 million in investments, Evidation is looking to expand its virtual research platform to include digital interventions and treatments, FierceBiotech reports.
According to the report, the platform already has some 4 million participants in the U.S.
“Participation in research is an activator for individuals to better understand their health and seek care proactively,” Evidation CEO Deborah Kilpatrick said in a statement. “The natural next step for Evidation is to decrease the latency between evidence and action by offering virtual health programs, while still keeping privacy and consent at the forefront.”
To read the full report, click here.